William G. Powderly

William G. Powderly publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where William G. Powderly sits on this spectrum.

William G. Powderly D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where William G. Powderly sits on this spectrum.

Research.com Recognitions

• 2001 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Best Publications

• Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

  John R. Perfect;William E. Dismukes;Francoise Dromer;David L. Goldman

  3193
  Citations

• Practice Guidelines for the Management of Cryptococcal Disease

  Michael S. Saag;Richard J. Graybill;Robert A. Larsen;Peter G. Pappas

  1453
  Citations

• A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow Transplantation

  Jesse L. Goodman;Drew J. Winston;Ronald A. Greenfield;Pranatharthi H. Chandrasekar

  1424
  Citations

• A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

  Peter G. Pappas;John H. Rex;Jeannette Lee;Richard J. Hamill

  1112
  Citations

• Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome

  van der Horst Cm;Saag Ms;Cloud Ga;Hamill Rj

  928
  Citations

• Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

  Sharon A. Riddler;Richard Haubrich;A. Gregory DiRienzo;Lynne Peeples

  869
  Citations

• The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection a double-blind, placebo-controlled trial

  M. A. Fischl;D. D. Richman;N. Hansen;A. C. Collier

  827
  Citations

• Comparison of Amphotericin B with Fluconazole in the Treatment of Acute AIDS-Associated Cryptococcal Meningitis

  M S Saag;W G Powderly;G A Cloud;P Robinson

  811
  Citations

• Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial

  Andrew R. Zolopa;Janet Andersen;Lauren Komarow;Ian Sanne

  712
  Citations

• Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy.

  Pablo Tebas;William G. Powderly;Sherry Claxton;Donna Marin

  684
  Citations

• Amphotericin B: current understanding of mechanisms of action.

  J Brajtburg;W G Powderly;G S Kobayashi;G Medoff

  682
  Citations

• Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States

  Luis Ostrosky-Zeichner;John H. Rex;Peter G. Pappas;Richard J. Hamill

  642
  Citations

• USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus

  David Lanier;Neil Schram;Ellen Cooper;Kenneth A. Freedberg

  630
  Citations

• Diagnosis and Management of Increased Intracranial Pressure in Patients with AIDS and Cryptococcal Meningitis

  J R Graybill;J Sobel;M Saag;C van Der Horst

  626
  Citations

• A Preliminary Study of Ritonavir, an Inhibitor of HIV-1 Protease, to Treat HIV-1 Infection

  Markowitz M;Saag M;Powderly Wg;Hurley Am

  601
  Citations

• Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.

  Morris Schambelan;Constance A. Benson;Andrew Carr;Judith S. Currier

  594
  Citations

• A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021

  W D Hardy;J Feinberg;D M Finkelstein;M E Power

  466
  Citations

• A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.

  W G Powderly;M S Saag;M S Saag;G A Cloud;G A Cloud;P Robinson;P Robinson

  440
  Citations

• A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection.

  S. A. Bozzette;D. M. Finkelstein;S. A. Spector;P. Frame

  422
  Citations

• Safety and Efficacy of Liposomal Amphotericin B Compared with Conventional Amphotericin B for Induction Therapy of Histoplasmosis in Patients with AIDS

  Philip C. Johnson;L. Joseph Wheat;Gretchen A. Cloud;Mitchell Goldman

  407
  Citations

• A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection

  William G. Powderly;Dianne M. Finkelstein;Judith Feinberg;Peter Frame

  406
  Citations